Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7728-40-7

Post Buying Request

7728-40-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7728-40-7 Usage

Chemical Properties

White Solid

Uses

MEGX has been used in an approach to improve the yield of N-dealkylated lidocaine.

Definition

ChEBI: Amino acid amide formed from 2,6-dimethylaniline and N-ethylglycine components; an active metabolite of lidocaine, formed by oxidative deethylation. Used as an indicator of hepatic function.

Biochem/physiol Actions

Monoethylglycinexylidide (MEGX) is an active metabolite of lidocaine.

Check Digit Verification of cas no

The CAS Registry Mumber 7728-40-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,2 and 8 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 7728-40:
(6*7)+(5*7)+(4*2)+(3*8)+(2*4)+(1*0)=117
117 % 10 = 7
So 7728-40-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H18N2O/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3/h5-7,13H,4,8H2,1-3H3,(H,14,15)

7728-40-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (SML0087)  MEGX  ≥95% (HPLC)

  • 7728-40-7

  • SML0087-5MG

  • 1,130.22CNY

  • Detail
  • Sigma

  • (SML0087)  MEGX  ≥95% (HPLC)

  • 7728-40-7

  • SML0087-25MG

  • 4,559.49CNY

  • Detail

7728-40-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name monoethylglycinexylidide

1.2 Other means of identification

Product number -
Other names monoethylglycine-2,6-xylidide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7728-40-7 SDS

7728-40-7Relevant articles and documents

MEANS AND METHODS FOR THE N-DEALKYLATION OF AMINES

-

Page/Page column 18; 19, (2017/11/10)

The invention relates to improved means and methods for N- dealkylation of alkylated amines. Provided is a method for the catalytic N- dealkylation of an N-alkylated amine substrate, comprising incubating said amine substrate in a suitable solvent in the

Iron-catalyzed Cα-H oxidation of tertiary, aliphatic amines to amides under mild conditions

Legacy, Christopher J.,Wang, Anqi,O'Day, Brian J.,Emmert, Marion H.

supporting information, p. 14907 - 14910 (2016/02/05)

De novo syntheses of amides often generate stoichiometric amounts of waste. Thus, recent progress in the field has focused on precious metal catalyzed, oxidative protocols to generate such functionalities. However, simple tertiary alkyl amines cannot be used as starting materials in these protocols. The research described herein enables the oxidative synthesis of amides from simple, noncyclic tertiary alkyl amines under synthetically useful, mild conditions through a biologically inspired approach: Fe-catalyzed Cα-H functionalization. Mechanistic investigations provide insight into reaction intermediates and allow the development of a mild Cα-H cyanation method using the same catalyst system. The protocol was further applied to oxidize the drug Lidocaine, demonstrating the potential utility of the developed chemistry for metabolite synthesis. Let′s iron it out! The title reaction enables the oxidative synthesis of amides directly from tertiary, noncyclic alkyl amines under synthetically useful, mild conditions through a biologically inspired approach employing oxidative iron catalysis. Mechanistic studies suggest that hemiaminals are likely intermediates in this reaction and that the catalytic system can be employed for other Cα-H oxidations of amines.

Preparation of human drug metabolites using fungal peroxygenases

Poraj-Kobielska, Marzena,Kinne, Matthias,Ullrich, Rene,Scheibner, Katrin,Kayser, Gernot,Hammel, Kenneth E.,Hofrichter, Martin

experimental part, p. 789 - 796 (2012/07/14)

The synthesis of hydroxylated and O- or N-dealkylated human drug metabolites (HDMs) via selective monooxygenation remains a challenging task for synthetic organic chemists. Here we report that aromatic peroxygenases (APOs; EC 1.11.2.1) secreted by the agaric fungi Agrocybe aegerita and Coprinellus radians catalyzed the H2O2-dependent selective monooxygenation of diverse drugs, including acetanilide, dextrorphan, ibuprofen, naproxen, phenacetin, sildenafil and tolbutamide. Reactions included the hydroxylation of aromatic rings and aliphatic side chains, as well as O- and N-dealkylations and exhibited different regioselectivities depending on the particular APO used. At best, desired HDMs were obtained in yields greater than 80% and with isomeric purities up to 99%. Oxidations of tolbutamide, acetanilide and carbamazepine in the presence of H218O2 resulted in almost complete incorporation of 18O into the corresponding products, thus establishing that these reactions are peroxygenations. The deethylation of phenacetin-d1 showed an observed intramolecular deuterium isotope effect [(kH/kD) obs] of 3.1 ± 0.2, which is consistent with the existence of a cytochrome P450-like intermediate in the reaction cycle of APOs. Our results indicate that fungal peroxygenases may be useful biocatalytic tools to prepare pharmacologically relevant drug metabolites.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7728-40-7